Loading viewer...
investor_presentation
Format: PDF investor_presentation
Helio sTechnologie s//Investo rPresentatio n1 Second Quarter 2022 Earnings Aug 9, 2022 Josef Matosevic –President & CEO Tricia Fulton –Chief Financial Officer Tania Almond –VP of IR, Corp. Comm., & Risk Mgmt.
Helio sTechnologie s//Investo rPresentatio n1
Second Quarter 2022 Earnings
Josef Matosevic –President & CEO
Tricia Fulton –Chief Financial Officer
Tania Almond –VP of IR, Corp. Comm., & Risk Mgmt.Helio sTechnologie s//Investo rPresentatio n2This presentation and oral statements made by management in connection herewith that are not historical facts are “forward‐lo oking statements” within the meaning of Section 21E of the
Securities Exchange Act of 1934. Forward‐looking statements involve risks and uncertainties, and actual results may differ ma terially from those expressed or implied by such statements. They
include statements regarding current expectations, estimates, forecasts, projections, our beliefs, and assumptions made by He lios Technologies, Inc. (“Helios” or the “Company”), its directors
or its officers about the Company and the industry in which it operates, and assumptions made by management, and include amon g other items, ( i) the Company’s strategies regarding
growth, including its intention to develop new products and make acquisitions; (ii) the effectiveness of creating the Center of Engineering Excellence; (iii) the Company’s financing plans; (iv)
trends affecting the Company’s financial condition or results of operations; (v) the Company’s ability to continue to control costs and to meet its liquidity and other financing needs; (vi) the
declaration and payment of dividends; and (vii) the Company’s ability to respond to changes in customer demand domestically a nd internationally, including as a result of standardization. In
addition, we may make other written or oral statements, which constitute forward -looking statements, from time to time. Words su ch as “may,” “expects,” “projects,” “anticipates,” “intends,”
“plans,” “believes,” “seeks,” “estimates,” variations of such words, and similar expressions are intended to identify such fo rward-looking statements. Similarly, statements that describe our
future plans, objectives or goals also are forward -looking statements. These statements are not guaranteeing future performance and are subject to a number of risks and uncertainties. Our
actual results may differ materially from what is expressed or forecasted in such forward -looking statements, and undue reliance should not be placed on such statements. All forward -looking
statements are made as of the date hereof, and we undertake no obligation to update any forward -looking statements, whether as a result of new information, future events or otherwise.
Factors that could cause the actual results to differ materially from what is expressed or forecasted in such forward‐looking statements include, but are not limited to, ( i) supply chain
disruption and the potential inability to procure goods; (ii) conditions in the capital markets, including the interest rate environment and the availability of capital; (iii) inflation (including
Preview truncated — download the full document for the complete content.
investor_presentation
32 Pages
investor_presentation
67 Pages
Weyerhaeuser
investor_presentation
4D Pharma